Search research articles
Contact Us
Filters
Showing results (1-10 of 190) with videos related to
Page
of 19
Sort By:
Infectious Disorders Drug Targets
|
March 17, 2011
Targeting tuberculosis and HIV/AIDS: a global progress report of a deadly partnership
Jean B Nachega, Bernd Rosenkranz
Infectious Disorders Drug Targets
|
January 14, 2014
Editorial: diagnosis and management of malaria: an updated report on a deadly disease of global impact
Bernd Rosenkranz, Jean B Nachega
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 8, 2003
Tuberculosis drug resistance: a global threat
Jean B Nachega, Richard E Chaisson
Infectious Disorders Drug Targets
|
March 17, 2011
Targeting HIV: past, present and future
Michèle D Zeier, Jean B Nachega
The Lancet. Infectious Diseases
|
November 25, 2006
HIV infection as a weapon of war
Edward J Mills, Jean B Nachega
Lancet (London, England)
|
December 11, 2007
A wake-up call for global access to salvage HIV drug regimens
Edward J Mills, Jean B Nachega
Patient Preference and Adherence
|
January 20, 2012
Twice-daily versus once-daily antiretroviral therapy and coformulation strategies in HIV-infected adults: benefits, risks, or burden?
Jean B Nachega, Bernd Rosenkranz, Paul A Pham
Current Opinion in HIV and AIDS
|
January 5, 2010
Antiretroviral therapy adherence and retention in care in middle-income and low-income countries: current status of knowledge and research priorities
Jean B Nachega, Edward J Mills, Mauro Schechter
International Journal of Epidemiology
|
May 8, 2013
Authors' response to: Epidemiology and public health research productivity in Africa
Jean B Nachega, Olalekan Uthman, Yu-Shan Ho
Global Health, Science and Practice
|
October 3, 2014
Can we stop AIDS with antiretroviral-based treatment as prevention?
Edward J Mills, Jean B Nachega, Nathan Ford
Page
of 19
Search research articles
Search
Showing results (1-10 of 190) with videos related to
Sort By:
Page
of 19
Infectious Disorders Drug Targets
|
March 17, 2011
Targeting tuberculosis and HIV/AIDS: a global progress report of a deadly partnership
Jean B Nachega, Bernd Rosenkranz
Infectious Disorders Drug Targets
|
January 14, 2014
Editorial: diagnosis and management of malaria: an updated report on a deadly disease of global impact
Bernd Rosenkranz, Jean B Nachega
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 8, 2003
Tuberculosis drug resistance: a global threat
Jean B Nachega, Richard E Chaisson
Infectious Disorders Drug Targets
|
March 17, 2011
Targeting HIV: past, present and future
Michèle D Zeier, Jean B Nachega
The Lancet. Infectious Diseases
|
November 25, 2006
HIV infection as a weapon of war
Edward J Mills, Jean B Nachega
Lancet (London, England)
|
December 11, 2007
A wake-up call for global access to salvage HIV drug regimens
Edward J Mills, Jean B Nachega
Patient Preference and Adherence
|
January 20, 2012
Twice-daily versus once-daily antiretroviral therapy and coformulation strategies in HIV-infected adults: benefits, risks, or burden?
Jean B Nachega, Bernd Rosenkranz, Paul A Pham
Current Opinion in HIV and AIDS
|
January 5, 2010
Antiretroviral therapy adherence and retention in care in middle-income and low-income countries: current status of knowledge and research priorities
Jean B Nachega, Edward J Mills, Mauro Schechter
International Journal of Epidemiology
|
May 8, 2013
Authors' response to: Epidemiology and public health research productivity in Africa
Jean B Nachega, Olalekan Uthman, Yu-Shan Ho
Global Health, Science and Practice
|
October 3, 2014
Can we stop AIDS with antiretroviral-based treatment as prevention?
Edward J Mills, Jean B Nachega, Nathan Ford
Page
of 19